Moreover, in terms of clinical outcomes, we found that HDAC4 expression and Sox2 expression were both negatively associated with survival in CRC, which matches a previous report that increased HDAC4 expression was associated with poor prognosis in esophageal cancer [44]. This evidence concerns the gene SOX2 and esophageal cancer.